Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat critically ill patients with serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers.

Print   Email View: All Filings Annual Quarterly Current Section 16 Proxy Other    Year: All Years 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 Filing Description Date Filed Size   4 blickenstaff, kim d Jul 14, 2010 19.8 KB 4 adams, daniel Jul 14, 2010 19.8 KB 4 vernon, w anthony Jul 14, 2010 19.8 KB 4 bailey, gregory Jul 14, 2010 19.8 KB 4 palekar, rohan May 18, 2010 19.5 KB 4 bailey, gregory Feb 23, 2010 19.4 KB 4 machado, clarence patrick Feb 22, 2010 19.3 KB 4 bailey, gregory Feb 11, 2010 19.4 KB 4 palekar, rohan Feb 3, 2010 21.3 KB 4 bailey, gregory Jan 29, 2010 19.4 KB 4 machado, clarence patrick Jan 20, 2010 19.5 KB 4 bailey, gregory Jan 15, 2010 19.4 KB 4 blickenstaff, kim d Jan 15, 2010 21.3 KB 4 bailey, gregory Dec 23, 2009 19.4 KB 4 bailey, gregory Dec 22, 2009 19.4 KB 4 bailey, gregory Dec 18, 2009 19.4 KB 4 palekar, rohan Dec 17, 2009 19.6 KB 4 machado, clarence patrick Dec 17, 2009 19.7 KB 4 seely, lynn Dec 17, 2009 19.7 KB 4 hung, david Dec 17, 2009 19.8 KB Showing 1-20 of 199 Page: 1 2 3 ... 10  Next 20 = add filing to Briefcase